- Home
- SABS vs UCAR Comparison
SABS vs UCAR Comparison
Compare SABS & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- UCAR
- Stock Information
- Founded
- SABS 2014
- UCAR 2013
- Country
- SABS United States
- UCAR China
- Employees
- SABS N/A
- UCAR N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- UCAR Retail-Auto Dealers and Gas Stations
- Sector
- SABS Health Care
- UCAR Consumer Discretionary
- Exchange
- SABS Nasdaq
- UCAR Nasdaq
- Market Cap
- SABS 23.9M
- UCAR 24.1M
- IPO Year
- SABS N/A
- UCAR 2023
- Fundamental
- Price
- SABS $3.34
- UCAR $7.00
- Analyst Decision
- SABS Strong Buy
- UCAR
- Analyst Count
- SABS 5
- UCAR 0
- Target Price
- SABS $12.40
- UCAR N/A
- AVG Volume (30 Days)
- SABS 83.3K
- UCAR 25.5K
- Earning Date
- SABS 11-06-2024
- UCAR 10-08-2024
- Dividend Yield
- SABS N/A
- UCAR N/A
- EPS Growth
- SABS N/A
- UCAR N/A
- EPS
- SABS N/A
- UCAR N/A
- Revenue
- SABS $1,512,723.00
- UCAR $4,273,899.00
- Revenue This Year
- SABS N/A
- UCAR N/A
- Revenue Next Year
- SABS N/A
- UCAR N/A
- P/E Ratio
- SABS N/A
- UCAR N/A
- Revenue Growth
- SABS N/A
- UCAR 473.55
- 52 Week Low
- SABS $2.16
- UCAR $4.21
- 52 Week High
- SABS $7.70
- UCAR $23.00
- Technical
- Relative Strength Index (RSI)
- SABS 48.06
- UCAR 44.32
- Support Level
- SABS $2.75
- UCAR $6.95
- Resistance Level
- SABS $4.30
- UCAR $7.79
- Average True Range (ATR)
- SABS 0.51
- UCAR 0.44
- MACD
- SABS 0.03
- UCAR 0.04
- Stochastic Oscillator
- SABS 26.11
- UCAR 27.32
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufactory and sales; battery swapping services and sourcing services. The company as a broker engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.